Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Decoy-20 by Indaptus Therapeutics for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Metastatic Adenocarcinoma of The Pancreas. According...
Decoy-20 by Indaptus Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
Decoy-20 by Indaptus Therapeutics for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Metastatic Transitional (Urothelial) Tract Cancer. According...
Decoy-20 by Indaptus Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
Decoy-20 by Indaptus Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Decoy-20 by Indaptus Therapeutics for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Metastatic Hepatocellular Carcinoma (HCC). According to...
Decoy-20 by Indaptus Therapeutics for Adenoid Cystic Carcinoma (ACC): Likelihood of Approval
Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Adenoid Cystic Carcinoma (ACC). According to...
Risk adjusted net present value: What is the current valuation of Indaptus Therapeutics's Decoy-20?
Decoy-20 is a biologic commercialized by Indaptus Therapeutics, with a leading Phase I program in Metastatic Transitional (Urothelial) Tract Cancer....